Effect of Effect of a Medicated Topical Therapy , Petrolatum, and No Treatment on Nocturnal Cough
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
This study seeks to subjectively evaluate whether a single application of Vicks® VapoRub® (VVR) ointment or a control ointment (petrolatum) will be superior to no treatment for control of nocturnal cough and congestion due to upper respiratory tract infection (URI) as rated by both parents and children.
Condition or disease
Respiratory Tract Diseases
Other: Ointment containing camphor, eucalyptus oil, and mentholOther: Petroleum jelly
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
2 Years to 11 Years (Child)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Cough and congestion attributed to upper respiratory tract infection
Children with signs or symptoms of more serious or treatable disease
Presence of itchy, watery eyes or frequent sneezing
Tachypnea (respiratory rate >95%ile) or labored breathing
Symptoms for 8 or more days
History of asthma in the past 2 years, chronic lung disease, or seizure disorder
History of an allergic reaction to camphor, menthol, eucalyptus, petrolatum, cedarleaf oil, nutmeg oil, thymol, turpentine oil, Over-the-counter medication containing VVR components